Key result
Application of blebbistatin or mechanosensitive channel blockers to fibrotic monolayers increased longitudinal conduction velocity from 14.4 to 35.9 cm/s and transverse velocity from 4.1 to 10.3 cm/s.
Myofibroblast-myocyte mechanical interactions impair cardiac conduction via increased mechanosensitive channel activation, suggesting a novel mechanism for arrhythmogenesis in fibrotic hearts.
No takes yet. Share an insight, caveat, or question.
Should not change clinical practice in fibrotic hearts; hypothesis-generating for mechanosensitive channel targeting in arrhythmogenesis.
Thompson et al. (2011) studied Cardiac fibrosis (in vitro model). Blebbistatin, gadolinium, or streptomycin vs. Untreated (control) and transforming growth factor-β-treated (fibrotic) monolayers was evaluated on Longitudinal conduction velocity, transverse conduction velocity, and normalized action potential upstroke velocity. Application of blebbistatin or mechanosensitive channel blockers to fibrotic monolayers increased longitudinal conduction velocity from 14.4 to 35.9 cm/s and transverse velocity from 4.1 to 10.3 cm/s.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: